How do I get my materials into an Isolator?

Fill/finish lines surrounded by RABS and/or Isolators come with many benefits, but one of the initial challenges is determining how to transfer commodities, fluid paths, tools or drug product itself into the closed ISO 5 space. Have no fear, Syntegon’s experts are here! Join Matthias Angelmaier and Dr. Laura Moody on Wednesday, May 12th at 10am CDT for the final chapter in Syntegon’s Isolator webinar series, as they describe the various techniques used to quickly and safely move materials across barriers and into the final fill production space. Click here to register.

Complete transparency: innovative Track and Trace solutions for the food industry

 

Product counterfeiting is a hot topic in almost all manufacturing industries; the demands for a clear proof of origin are increasing. Particularly regarding the growing number of scandals involving counterfeit or contaminated food products, it is essential to take action as quickly as possible – to strengthen confidence in one’s own brand and to avoid expensive product recalls. …More

Join Syntegon at the 2021 Virtual Pharma Expo

Join Syntegon at the 2021 Virtual Pharma Expo series event, focused on Oral Solid Dose Manufacturing. On Wednesday, May 5 at 9:30am EDT, Head of Pharma Service and Senior Scientist/Pharmacist Marc Michaelis will be presenting on Continuous Manufacturing. Learn about the benefits of moving from batch production to a continuous process.

Learn more about the event, and register for free here.

Next chapter in Isolator webinar series

On Wednesday, April 28th, the next chapter in Syntegon’s Isolator webinar series launches. Our experts Stefan Schuh, Dr. Laura Moody and Matthias Angelmaier will lead our free event, “How to handle complex isolator lines: Insights into the project life cycle of a liquid lyo-line”. Join them to learn more …More

Automated Capsule Product Development comes to the US at Syntegon’s Partner, Parsolex

Developing an oral solid dosage (OSD) product is not easy; timelines are long, financial risks are considerable and challenges are many. Consequently, significant incentive exists to find efficiencies and streamline the product development process wherever possible. However, one aspect of the pharma development process remains unchanged. Regulatory agencies are unwavering in their demand for evidence that your manufacturing process is stable and the design space well defined; …More

Filling pharmaceutical powders efficiently and safely

Pharmaceutical powders form the basis for many antibiotics that are essential for comprehensive medical care. In this interview, Markus Heinz, product manager at Syntegon, explains which changes are currently taking place in the market and which challenges antibiotic manufacturers are facing in powder filling. …More

For effective moist heat terminal sterilization for large/small volume parenteral products, Syntegon delivers leading performance

Whenever feasible, regulatory agencies require injectable products to be terminally sterilized. Due to somewhat fragile molecules and compounds, this aseptic process may render the intended product to be adversely impacted and not endure the stress that moist-heat processes may subject them to. However, for those products that are more compatible to the heat and exposure, …More

Top of page